Table 4.
Adjusted relationship between total IBD-SES score and daily life impact of IBD
| Patient characteristic | β | 95% CI | P |
| IBD-SES score | −0.09 | −0.12 to −0.061 | <0.001a |
| Age (yr) | |||
| 18–30 | — | — | — |
| 31–49 | 1.63 | −1.45 to 4.72 | 0.296 |
| 50–69 | 2.06 | −0.92 to 5.05 | 0.174 |
| 70 or older | −0.15 | −4.10 to 3.79 | 0.939 |
| Female sex | 1.68 | 0.37 to 3.72 | 0.108 |
| IBD type | |||
| Crohn's disease | — | — | — |
| Ulcerative colitis | 2.91 | 0.52 to 4.29 | 0.017a |
| Indeterminate colitis | −2.89 | −12.17 to 6.39 | 0.539 |
| Unknown | −2.42 | −8.43 to 3.60 | 0.429 |
| Clinically active disease | 5.03 | 1.62 to 8.43 | 0.004a |
| Moderate-to-severe disease | 0.77 | −1.97 to 3.51 | 0.581 |
| Depression | 1.71 | −1.07 to 4.49 | 0.227 |
| Anxiety | −2.59 | −4.92 to −0.28 | 0.029a |
CI, confidence interval; IBD, inflammatory bowel disease; IBD-SES, IBD Self-Efficacy Scale.
Statistical significant to P < 0.05 or smaller.